Similar articles for PMID: 22232308

Year	Number of Results
1915	1
1977	1
1991	1
1993	1
1996	1
1998	2
2000	2
2001	2
2003	5
2004	1
2005	6
2006	14
2007	9
2008	8
2009	8
2010	9
2011	11
2012	8
2013	7
2014	8
2015	8
2016	6
2017	2
2018	6
2019	3
2020	4
2021	8
2022	12
2023	4
2024	0

1

The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.

O'Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, Baxter R, Davis RL, Izurieta HS, Lieu TA, Ball R. O'Leary ST, et al. Pediatrics. 2012 Feb;129(2):248-55. doi: 10.1542/peds.2011-1111. Epub 2012 Jan 9. Pediatrics. 2012. PMID: 22232308

2

Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.

Shinefield H, Black S, Thear M, Coury D, Reisinger K, Rothstein E, Xu J, Hartzel J, Evans B, Digilio L, Schödel F, Brown ML, Kuter B; 013 Study Group for ProQuad. Shinefield H, et al. Pediatr Infect Dis J. 2006 Apr;25(4):287-92. doi: 10.1097/01.inf.0000207857.10947.1f. Pediatr Infect Dis J. 2006. PMID: 16567978 Clinical Trial.

3

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.

Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI. Zangwill KM, et al. Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977. Pediatrics. 2008. PMID: 19047220

4

Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with measles-mumps-rubella and varicella vaccines in children less than 2 years of age.

Rinderknecht S, Michaels MG, Blatter M, Gaglani M, Andrews W, Abughali N, Chandreshekaran V, Trofa AF. Rinderknecht S, et al. Pediatr Infect Dis J. 2011 Oct;30(10):e179-85. doi: 10.1097/INF.0b013e31822256a5. Pediatr Infect Dis J. 2011. PMID: 21617573 Clinical Trial.

5

Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.

Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D. Nolan T, et al. Pediatrics. 2006 Sep;118(3):e602-9. doi: 10.1542/peds.2005-2755. Pediatrics. 2006. PMID: 16950952 Clinical Trial.

6

Simultaneous vaccination of Chinese applicants for a United States immigrant visa.

Hua L, Hongtao H, Shunqin W, Jinping G, Jiandong C, Zhaoliang L, Xinwen F. Hua L, et al. Travel Med Infect Dis. 2008 May;6(3):130-6. doi: 10.1016/j.tmaid.2008.03.004. Travel Med Infect Dis. 2008. PMID: 18486068

7

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov. Bisgard KM, et al. Pediatrics. 2005 Aug;116(2):e285-94. doi: 10.1542/peds.2004-2759. Pediatrics. 2005. PMID: 16061582

8

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases. America Academy of Pediatrics Commitee on Infectious Diseases. Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28. Pediatrics. 2006. PMID: 16382131

9

Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.

Trofa AF, Klein NP, Paul IM, Michaels MG, Goessler M, Chandrasekaran V, Blatter M. Trofa AF, et al. Pediatr Infect Dis J. 2011 Sep;30(9):e164-9. doi: 10.1097/INF.0b013e31821b8a7d. Pediatr Infect Dis J. 2011. PMID: 21494175 Clinical Trial.

10

Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.

Black S, Friedland LR, Ensor K, Weston WM, Howe B, Klein NP. Black S, et al. Pediatr Infect Dis J. 2008 Apr;27(4):341-6. doi: 10.1097/INF.0b013e3181616180. Pediatr Infect Dis J. 2008. PMID: 18316985 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

140 results

Results by year